Cell Gene Therapy Explained: Where CAR-T Meets CRISPR
Cell therapy and gene therapy are often used interchangeably, but the FDA treats them as distinct categories. This guide breaks down cell gene therapy through real examples like CAR-T and Casgevy, plus the emerging 2026 hybrid treatments blurring the line between the two.
Regenerative Medicine New Jersey: Costs, Coverage & Credibility in 2026
Regenerative medicine in New Jersey is booming, but not all providers are equally credible. This guide breaks down real costs, insurance coverage, and the regulatory landscape so patients can make informed decisions in 2026.
Regenerative Medicine Companies: The 2026 Credibility Framework
Standard ‘top companies’ lists rank regenerative medicine companies by revenue or patents, but say nothing about clinical credibility or regulatory compliance. This article offers a three-pillar framework—regulatory status, manufacturing accreditation, and scientific evidence—to help investors, clinicians, and patients separate legitimate providers from risky stem cell clinics.